Literature DB >> 11906814

Proliferative vitreoretinopathy: risk factors and pathobiology.

J Carlos Pastor1, E Rodríguez de la Rúa, Francisco Martín.   

Abstract

Proliferative vitreoretinopathy (PVR) is still a major cause of failure of retinal detachment surgery. Despite a dramatic increase in our pathobiologic knowledge of PVR during the last 10 years, little of this information has been used to modify the surgical management of the disease, and, thus, the anatomic and functional results are still unsatisfactory. Collaborative research involving clinicians and basic researchers must be encouraged. PVR must be considered a multifactorial disease caused by interaction of several cells and intra- and extraocular factors. Therefore, therapeutic options based on the inhibition of one factor or phenomenon may be regarded with scepticism. To prevent PVR, it is necessary to determine the factors involved in its development, and because of its relatively small prevalence, large, prospective, multicenter studies seem necessary. In addition, clinical research must not be underestimated. PVR affects both sides of the retina and the retina itself, a point to which little attention has been paid and that is critical for surgical results. Therefore, a new classification that provides information about clinical relevance, such as the evolutionary stages of the disease (biologic activity) and the degree of surgical difficulty (location of the fibrotic process), seems necessary.

Entities:  

Mesh:

Year:  2002        PMID: 11906814     DOI: 10.1016/s1350-9462(01)00023-4

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  111 in total

1.  Conventional buckling surgery or primary vitrectomy with silicone oil tamponade in rhegmatogenous retinal detachment with multiple breaks.

Authors:  Filiz Afrashi; Tansu Erakgun; Cezmi Akkin; Mahmut Kaskaloglu; Jale Mentes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-09       Impact factor: 3.117

2.  The effects of pleiotrophin in proliferative vitreoretinopathy.

Authors:  Xue Ding; Yujing Bai; Xuemei Zhu; Tianqi Li; Enzhong Jin; Lvzhen Huang; Wenzhen Yu; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-12       Impact factor: 3.117

3.  Vitreous Substitutes.

Authors:  William Joseph Foster
Journal:  Expert Rev Ophthalmol       Date:  2008-04

Review 4.  Regenerative therapies for central nervous system diseases: a biomaterials approach.

Authors:  Roger Y Tam; Tobias Fuehrmann; Nikolaos Mitrousis; Molly S Shoichet
Journal:  Neuropsychopharmacology       Date:  2013-09-04       Impact factor: 7.853

5.  Scleral buckling surgery for rhegmatogenous retinal detachment with subretinal proliferation.

Authors:  K Ghasemi Falavarjani; S A Alemzadeh; M Modarres; M M Parvaresh; M Hashemi; M Naseripour; H Nazari Khanamiri; S Askari
Journal:  Eye (Lond)       Date:  2015-01-23       Impact factor: 3.775

6.  Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.

Authors:  Bongsu Kim; Mohamed H Abdel-Rahman; Tiffany Wang; Severin Pouly; Ashraf M Mahmoud; Colleen M Cebulla
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-03       Impact factor: 4.799

7.  Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.

Authors:  K Ghasemi Falavarjani; M Hashemi; M Modarres; A Hadavand Khani
Journal:  Eye (Lond)       Date:  2014-02-21       Impact factor: 3.775

8.  Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.

Authors:  Takeshi Kita; Yasuaki Hata; Ryoichi Arita; Shuhei Kawahara; Muneki Miura; Shintaro Nakao; Yasutaka Mochizuki; Hiroshi Enaida; Yoshinobu Goto; Hiroaki Shimokawa; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

9.  The genomic response of the retinal pigment epithelium to light damage and retinal detachment.

Authors:  Amir Rattner; Leila Toulabi; John Williams; Huimin Yu; Jeremy Nathans
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

10.  The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.

Authors:  Ernesto Bali; Eric J Feron; Ed Peperkamp; Marc Veckeneer; Paul G Mulder; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.